Home

Regolarità misurare sindrome stada arzneimittel investor relations acidità Secondo grado mercoledì

Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG
STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG

IR Contact - Investor Relations | STADA
IR Contact - Investor Relations | STADA

Persona che tiene il cellulare con il logo della società tedesca Stada  Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a  fuoco sul display del telefono Foto stock -
Persona che tiene il cellulare con il logo della società tedesca Stada Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a fuoco sul display del telefono Foto stock -

STADA and Alvotech broaden European patients' options by launching  Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech

STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug |  Investor
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor

Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA

Nidda Healthcare GmbH - Investor Relations
Nidda Healthcare GmbH - Investor Relations

Investor Relations | STADA
Investor Relations | STADA

Investor Relations | STADA
Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

Ad hoc Releases - Stock - Investor Relations | STADA
Ad hoc Releases - Stock - Investor Relations | STADA

Corporate Presentation Investor Relations, May 2015
Corporate Presentation Investor Relations, May 2015

Annual General Meeting 2020 - Investor Relations | STADA
Annual General Meeting 2020 - Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

IR Contact - Investor Relations | STADA
IR Contact - Investor Relations | STADA

STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug |  Investor
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor

Investor Relations | STADA
Investor Relations | STADA

Hemofarm - News - STADA Health Report: 81 percent of Europeans are open  towards genetic testing
Hemofarm - News - STADA Health Report: 81 percent of Europeans are open towards genetic testing

Press release: STADA ranks among top 10% of pharma firms on sustainability  | Presseportal
Press release: STADA ranks among top 10% of pharma firms on sustainability | Presseportal

Investor Relations | STADA
Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

Investor Relations | STADA
Investor Relations | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

STADA diventa uno dei principali player del settore farmaceutico
STADA diventa uno dei principali player del settore farmaceutico

Investor Relations | STADA
Investor Relations | STADA

Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili
Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili